News - 東生華製藥

Home / News

TSH Board of Directors Approved the Consolidated Financial Statements For the Three Months Ended March 31, 2025

TSH Board of Directors Approved the Consolidated Financial Statements For the Three Months Ended March 31, 2025

2025.5.8

...

To announce the change of internal audit officer.

To announce the change of internal audit officer.

2025.4.30

...

To announce the change of internal audit officer.

To announce the change of internal audit officer.

2025.4.18

...

Announcement on behalf of major subsidiary, CHUANG YI BIOTECH CO., LTD.,of executive personnel change

Announcement on behalf of major subsidiary, CHUANG YI BIOTECH CO., LTD.,of executive personnel change

2025.3.24

...

TSH Biopharm was invited to attend the institutional investor conference hosted by Reliance Securities

TSH Biopharm was invited to attend the institutional investor conference hosted by Reliance Securities

2025.3.13

...

TSH Board of Directors resolved to convene the 2025 Annual General Shareholders' Meeting

TSH Board of Directors resolved to convene the 2025 Annual General Shareholders' Meeting

2025.2.21

...